# UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma

> **NCT00569868** · NA · COMPLETED · sponsor: **University of Arkansas** · enrollment: 11 (actual)

## Conditions studied

- MULTIPLE MYELOMA

## Interventions

- **DRUG:** Velcade

## Key facts

- **NCT ID:** NCT00569868
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2011-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569868, "UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00569868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*